June 2022 in “Value in Health” Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.
January 1997 in “International Society of Hair Restoration Surgery”
January 2020 in “SCIENCE, ENGINEERING AND TECHNOLOGY: GLOBAL TRENDS, PROBLEMS AND SOLUTIONS” I'm sorry, but I can't provide the information you're looking for.
14 citations
,
January 2025 in “Journal of Dermatological Treatment” Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.
May 2023 in “Zenodo (CERN European Organization for Nuclear Research)” October 1993 in “The Journal of Clinical Pharmacology”
25 citations
,
November 2022 in “British journal of dermatology/British journal of dermatology, Supplement” Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.
Baricitinib helps regrow hair in teens with severe alopecia areata.
August 2016 in “Journal of Investigative Dermatology” July 2024 in “Journal of Investigative Dermatology” PP405 may help hair growth by activating hair follicle stem cells.
January 2025 in “KeiO Associated Repository of Academic Resources (Keio University)”
March 2012 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
21 citations
,
November 1980 in “PubMed” A new mite species was found in California sea lions, causing skin issues.
July 2010 in “Hair transplant forum international” The ABHRS held a test in Capri, Italy.
November 2009 in “Cambridge University Press eBooks” The document's conclusion cannot be provided because the content is not accessible.
7 citations
,
February 2011 in “Journal of dermatology” The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.
July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” July 2022 in “Zenodo (CERN European Organization for Nuclear Research)” June 2022 in “Zenodo (CERN European Organization for Nuclear Research)” July 1995 in “Journal of Dermatological Science”
June 2025 in “The Journal of Dermatology” Baricitinib is effective and safe for long-term treatment of severe alopecia areata.
March 1997 in “Hair transplant forum international” The document's content couldn't be understood or processed.
November 2006 in “評価・診断に関するシンポジウム講演論文集” KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.
March 2022 in “Journal of Maxillofacial and Oral Surgery” I'm sorry, but I can't provide a summary as I don't have the specific details about the "45th AOMSI Conference".
1 citations
,
September 2023 in “Journal of the American Academy of Dermatology” Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.
2 citations
,
September 2023 in “Journal of the American Academy of Dermatology” Baricitinib is a safe and effective treatment for severe alopecia areata.
January 2025 in “Journal of Cutaneous Immunology and Allergy” Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.
November 2025 in “Journal of Clinical Medicine” Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.